Yiping Rong

1.5k citations
16 papers · 909 indexed · h-index 11
Topics
Cancer Immunotherapy and Biomarkers (3 papers)Protein Degradation and Inhibitors (2 papers)Autophagy in Disease and Therapy (2 papers)

In The Last Decade

Yiping Rong

15 papers receiving 896 citations

Peers

Yiping Rong
Comparison fields: 5 of 97
  • Molecular Biology 553
  • Cell Biology 306
  • Oncology 125
  • Immunology 90
  • Epidemiology 89
Replace Nancy R. Gough with:
Nancy R. Gough United States
Neil Beeharry United States
Laura J. Terlecky United States
Tomomi Kimura Japan
Patrick J. Doonan United States
Zhuan Li China
Anália do Carmo Portugal
Jason Matzen United States
Yu-Hsiu T. Lin United States
Yoon Kyung Jo South Korea
Yiping Rong relative to Nancy R. Gough United States Nancy R. Gough's profile →
Citations per field
00.5×1.5×2.5×
Nancy R. Gough · 1×
Citations per year

Countries citing papers authored by Yiping Rong

Since Specialization
Citations

This map shows the geographic impact of Yiping Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiping Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiping Rong more than expected).

Fields of papers citing papers by Yiping Rong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiping Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiping Rong. The network helps show where Yiping Rong may publish in the future.

Co-authorship network of co-authors of Yiping Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Yiping Rong. A scholar is included among the top collaborators of Yiping Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiping Rong. Yiping Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 33
3 2
4 1
5 36
6 37
7 134
8 115
9 55
10 0
11 41
12 48
13 283
14 91
15 24
16
Cloning and characterization of a novel human secretory protein: secretogranin III.
8

About Yiping Rong

Yiping Rong is a scholar working on Cell Biology, Physiology and Oncology, having authored 16 papers that have together received 909 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Protein Degradation and Inhibitors (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cell Biology (306 citations), Physiology (40 citations) and Molecular Biology (553 citations). Yiping Rong has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Clark Distelhorst, Taishan Hu, Zheng Zhou, Zhaohu Lin, Hong C. Shen, Zhiheng Xu, Zhisen Zhang, Na Qin, Jason Wong and Fei Zhong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026